Novel titanocene anti-cancer drugs derived from fulvenes and titanium dichloride

Journal of Organometallic Chemistry

Volumn 689, Issue 13, 2004, Pages 2242-2249

  Tacke, Matthias ^a   Allen, Lorcan T ^a   Cuffe, Laurence ^a   Gallagher, William M ^a   Lou, Ying ^a   Mendoza, Oscar ^a   Müller Bunz, Helge ^a   Rehmann, Franz Josef K ^a   Sweeney, Nigel ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

A2780 cp70; Anti cancer drug; cis Platinum; Fulvene; LLC PK; Titanocene

Indexed keywords

[1,2 DI(CYCLOPENTADIENYL) 1,2 BIS(PENTAMETHYLPHENYL)ETHANEDIYL] TITANIUM DICHLORIDE; [1,2 DI(CYCLOPENTADIENYL) 1,2 DI(4 N,N DIMETHYLAMINOPHENYL)ETHANEDIYL] TITANIUM DICHLORIDE; ANILINE DERIVATIVE; ANTINEOPLASTIC AGENT; CYANIC ACID DERIVATIVE; CYCLOALKENE; CYCLOPENTADIENE DERIVATIVE; DITHIOL DERIVATIVE; FULVENE DERIVATIVE; METHYL GROUP; TITANIUM DERIVATIVE; TITANOCENE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CARCINOMA CELL; CONTROLLED STUDY; CYTOTOXICITY; DRUG SYNTHESIS; HUMAN; HUMAN CELL; IC 50; KIDNEY CARCINOMA; NONHUMAN; OVARY CARCINOMA;

STAPHYLOCOCCUS PHAGE 3A; SUS SCROFA;

EID: 2542432229     PISSN: 0022328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jorganchem.2004.04.015     Document Type: Article

References (27)

1. Gelasco A. Lippard S.J. Top. Biol. Inorg. Chem. 1 1999 1
2. Jamieson E.R. Lippard S.J. Chem. Rev. 99 1999 2467
3. Farrell N. Qu Y. Roberts J.D. Top. Biol. Inorg. Chem. 1 1999 99
4. Köpf-Maier P. Köpf H. Chem. Rev. 87 1987 1137
5. Köpf-Maier P. Köpf H. Struct. Bond. 70 1988 105
6. Christodoulou C.V. Ferry D.R. Fyfe D.W. Young A. Doran J. Sheehan T.M. Eliopoulos A. Hale K. Baumgart J. Saß G. Kerr D.J. J. Clin. Oncol. 16 1998 2761
7. Korfel A. Scheulen M.E. Schmoll H.J. Grundel O. Harstrick A. Knoche M. Fels M. Skorzec M. Bach F. Baumgart J. Saß G. Seeber S. Thiel E. Berdel W.E. Clin. Cancer Res. 4 1998 2701
8. Lummen G. Sperling H. Luboldt H. Otto T. Rubben H. Cancer Chemother. Pharmacol. 42 1998 415
9. Kröger N. Kleeberg U.R. Mross K. Edler L. Saß G. Hossfeld D.K. Onkologie 23 2000 60
10. Mokdsi G. Harding M.M. Metal-Based Drugs 5 1998 207
11. Allen O.R. Croll L. Gott A.L. Knox R.J. McGowan P.C. Organometallics 23 2004 288
12. Boyles R.J. Baird M.C. Campling B.G. Jain N. J. Inorg. Biochem. 84 2001 159
13. Teuber R. Linti G. Tacke M. J. Organomet. Chem. 545-546 1997 105
14. Hartl F. Cuffe L. Dunne J.P. Fox S. Mahabiersing T. Tacke M. J. Mol. Struct. 559 2001 331
15. Tacke M. Dunne J.P. Fox S. Linti G. Teuber R. J. Mol. Struct. 570 2001 197
16. Fox S. Dunne J.P. Dronskowski R. Schmitz D. Tacke M. Eur. J. Inorg. Chem. 2002 3039
17. Eisch J.J. Shi X. Owuor F.A. Organometallics 17 1998 5219
18. Eisch J.J. Owuor F.A. Shi X. Organometallics 18 1999 1583
19. Kane K.M. Shapiro P.J. Vij A. Cubbon R. Rheingold A.L. Organometallics 16 1997 4571
20. Fox S. Dunne J.P. Tacke M. Gallagher J.F. Inorg. Chim. Acta 357 2004 225
21. Sheldrick G.M. SADABS, Version 2.03 2002 University of Göttingen Germany
22. Sheldrick G.M. SHELXS 97 and SHELXL 97 1997 University of Göttingen Germany
23. Gaussian Inc., Carnegie Office Park, Building 6, Suite 230, Carnegie, PA 15106, USA
24. Stone K.J. Little R.D. J. Org. Chem. 49 1984 1849
25. Giddings S.A. Inorg. Chem. 6 1967 849
26. Mosmann T. J. Immunol. Methods 65 1983 55
27. Christodoulou C.V. Eliopoulos A.G. Young L.S. Hodgkins L. Ferry D.R. Kerr D.J. Br. J. Cancer 77 1998 2088